Why this top Australian stock could rise 30% in 12 months

Bell Potter thinks this stock is dirt cheap at current levels.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market has historically provided investors with an average annual return of approximately 10%.

While this return is excellent, you don't have to settle for that.

Not when there is one top Australian stock that has been tipped to triple this return over the next 12 months.

And that doesn't even include its attractive dividend yield.

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.

Image source: Getty Images

Which Australian stock?

The stock in question is Elders Ltd (ASX: ELD). It is an agribusiness company and leading supplier of fertiliser, agricultural chemicals, and animal health products to rural and regional Australia, with strong agency positions in livestock, wool, and real estate.

According to a note out of Bell Potter, its analysts have been looking over recent industry data to get an idea of how the company is performing.

The broker highlights that first quarter drivers are looking stronger than a year ago. It said:

Our indexed value of industry livestock turnoff was up +68% YOY through 1Q25 and remains elevated through 2Q25 (+24% QTD). Comparisons in 2H25 become more difficult, but we would expect rainfall in the south could be a major cattle price driver, with the EYCI-US90CL discount at a historically high level. Wool activity has been softer, with volume down -10% YOY and the EMI down -1% YOY.

Commenting on crop protection and crop inputs, Bell Potter adds:

Active ingredient values have remained fairly static over 4Q24-2Q25 and a highlight of the US reporting season has been a recovery in 1Q25 formulator and distributor margins to historical levels. In addition, we note domestic formulators (DGL, RDX) have reported reasonably strong demand from the agricultural sector. Crop nutrient values (urea/DAP) have also been tracking ahead of our expectations, with forward rates implying a +8-13% YOY gains in DAP and urea.

Big return potential

In light of the above, the broker has retained its buy rating on the Australian stock with a slightly trimmed price target of $9.40 (from $9.45).

Based on its current share price of $7.03, this implies potential upside of 34% for investors over the next 12 months.

In addition, the broker is forecasting a partially franked dividend of 36 cents per share in FY 2025 and then a fully franked dividend of 43 cents per share in FY 2026. This equates to dividend yields of 5.1% and 6.1%, respectively, which boosts the total potential return to almost 40%.

Bell Potter concludes:

Our Buy rating is unchanged. We would expect many of the issues that plagued 1Q24 have largely unwound in 1Q25 and as such would anticipate a more normal phasing in earnings in FY25e. We remain of the view that the Delta-Elders overlap is limited and manageable (we note the ACCC's final Supermarkets review is also overdue) and would see this a catalyst for momentum to return.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Elders. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »